Effectiveness and safety of continuous administration of tolvaptan in the treatment of refractory congestive heart failure in a multicenter cohort study
Not Applicable
- Conditions
- refractory congestive heart failure
- Registration Number
- JPRN-UMIN000010872
- Lead Sponsor
- Hyogo College of Medicine, Division of Cardiovascular Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
none
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Functional heart failure status
- Secondary Outcome Measures
Name Time Method 1) change in body weight 2) change in congestion (edema, rales) 3) Blood test (CBC, serum Na, serum K, Uric acid, BUN, Cre) 4) serum osmolality 5) plasma BNP concentration 6) urinary osmolality 7) change in UCG findings 8) change in ECG findings